Feature | March 09, 2015

Registry will help providers meet Medicare reporting requirements for low-dose CT lung cancer screening reimbursements

CMS, ACR, Lung Cancer Screening Registry, CT systems

March 9, 2015 — Providers can now meet Medicare quality reporting requirements to receive payment for computed tomography (CT) lung cancer screening by submitting data to the new Centers for Medicare & Medicaid Services (CMS)-approved American College of Radiology (ACR) Lung Cancer Screening Registry.

“The ACR Lung Cancer Screening Registry is ready to help providers quickly and efficiently meet Medicare reporting requirements and monitor and demonstrate the quality of CT lung cancer screening in their practice,” said Ella Kazerooni, M.D., FACR, chair of the American College of Radiology Lung Cancer Screening Committee and ACR Thoracic Imaging Panel. The ACR registry will also compile quality information that can help improve and refine lung cancer screening care over time at the national level.”

The ACR strongly encourages all providers considering or already offering CT lung cancer screening to utilize existing ACR tools and infrastructure to help ensure quality care:

  • The ACR Lung Cancer Screening Center program helps ensure these exams are provided safely and effectively;
  • ACR Lung-RADS standardizes CT lung cancer screening reporting and management, aids lung CT interpretation and supports outcomes monitoring; and
  • ACR/Society of Thoracic Radiology CT lung cancer screening practice parameters outline exam performance.

 

The college will also offer a number of lung cancer screening sessions at ACR 2015, the all-new ACR annual meeting, May 17–21 at the Marriott Wardman Park Hotel in Washington, D.C. These include:

  • Lung Cancer Screening Q & A With the Experts: LungRADS™, Registry and Reimbursement
  • Lung Cancer Screening: From Science to Practice
  • Lung Cancer Screening: CT Interpretation and Management
  • Lung Cancer Screening: Implementations and Economic Considerations for a Screening Program
  • Approach to Diffuse Lung Disease - Radiologic-Pathologic Correlation

 

The ACR Lung Cancer Screening Registry is part of the ACR National Radiology Data Registry (NRDR) that CMS has recognized for the Physician Quality Reporting System (PQRS).

For more information: www.cms.gov


Related Content

News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now